2023 Speaker Faculty | Kisaco Research

2023 Speaker Faculty

Microbiome Connect: EUROPE 2023
5-6 July, 2023
AMSTERDAM, NETHERLANDS
  • Author:

    Staffan Stromberg

    CEO
    Infant Bacterial Therapeutics

    Staffan Stromberg

    CEO
    Infant Bacterial Therapeutics
  • Author:

    Pedro Correa de Sampaio

    CEO
    Neobe Therapeutics

    Pedro Correa de Sampaio

    CEO
    Neobe Therapeutics
  • Author:

    Romain Daillere

    Head of Preclinical Research, Co-Founder
    Everimmune

    Romain Daillere

    Head of Preclinical Research, Co-Founder
    Everimmune
  • Author:

    Jean-Luc Marsat

    CEO
    Everimmune

    Jean-Luc Marsat

    CEO
    Everimmune
  • Author:

    Sandrine Claus

    CSO
    YSOPIA

    Sandrine Claus

    CSO
    YSOPIA
  • Author:

    Benjamin Hadida

    CEO & Co-founder
    Exeliom

    Benjamin Hadida

    CEO & Co-founder
    Exeliom
  • Author:

    Sam Possemiers

    CEO
    MRM Health

    Sam Possemiers

    CEO
    MRM Health
  • Author:

    Tomas De Wouters

    CEO
    PharmaBiome

    Tomas De Wouters

    CEO
    PharmaBiome
  • Author:

    Osnat Tirosh

    Head of Microbiome Research and Innovation
    Biomica

    Osnat Tirosh

    Head of Microbiome Research and Innovation
    Biomica
  • Author:

    Juan Basterra

    CEO
    Mikrobiomik

    Juan Basterra

    CEO
    Mikrobiomik
  • Author:

    Karine Roget

    CSO
    Nexbiome Tx

    Karine Roget

    CSO
    Nexbiome Tx
  • Author:

    Denise Kelly

    Investment Advisor
    Seventure Partners

    Denise Kelly

    Investment Advisor
    Seventure Partners
  • Author:

    Eric Van der Helm

    VP Scientific Affairs, Bioinformatics & Automation
    SNIPR Bio

    Eric Van der Helm

    VP Scientific Affairs, Bioinformatics & Automation
    SNIPR Bio
  • Author:

    Anna Chwalibog

    CEO, Co-founder
    Integral Solutions

    Anna Chwalibog

    CEO, Co-founder
    Integral Solutions
  • Author:

    Evelina Vågesjö, PhD MBA

    CEO
    Ilya Pharma

    Co-founder of and developed the concept during PhD 2011-2016, is now CEO and heading the drug and business development in Ilya Pharma. Also BSc in Management Accounting and finished an MBA 2018. Raised >4.3 M€ in grant funding to the project, lead the first private share issue in 2017 and designed stock option programs for key employees.  

    Evelina Vågesjö, PhD MBA

    CEO
    Ilya Pharma

    Co-founder of and developed the concept during PhD 2011-2016, is now CEO and heading the drug and business development in Ilya Pharma. Also BSc in Management Accounting and finished an MBA 2018. Raised >4.3 M€ in grant funding to the project, lead the first private share issue in 2017 and designed stock option programs for key employees.  

  • Author:

    Nathalie Corvaia

    CSO
    MaaT Pharma

    Nathalie Corvaia

    CSO
    MaaT Pharma
  • Author:

    Chrysi Sergaki

    Principal Investigator - Microbiome Group Leader
    MHRA

    Chrysi Sergaki

    Principal Investigator - Microbiome Group Leader
    MHRA
  • Author:

    Yuri Martina

    CMO
    Destiny Pharma

    Yuri Martina

    CMO
    Destiny Pharma
  • Author:

    Kristen Albright

    CEO
    Prokarium

    Kristen Albright

    CEO
    Prokarium
  • Author:

    Steve Emery

    CSO
    Chain Biotech

    Steve Emery

    CSO
    Chain Biotech
  • Author:

    Sarah Lebeer

    Professor
    University of Antwerp

    Sarah Lebeer

    Professor
    University of Antwerp
  • Author:

    Ruben Vazquez Uribe

    Co-principal Investigator
    Novo Nordisk Foundation Center for Biosustainability

    Ruben Vazquez Uribe

    Co-principal Investigator
    Novo Nordisk Foundation Center for Biosustainability
  • Author:

    Samantha Coulson

    Head of Clinical Research
    Servatus

    Samantha Coulson

    Head of Clinical Research
    Servatus
  • Author:

    Nicolas Pichon

    Head of Production
    Servatus

    Nicolas Pichon

    Head of Production
    Servatus
  • Author:

    Adam Baker

    Director of Sciences
    Chr. Hansen

    Adam Baker

    Director of Sciences
    Chr. Hansen
  • Author:

    Harriet Schellekens

    Lecturer
    University College Cork

    Harriet Schellekens

    Lecturer
    University College Cork
  • Author:

    Pilar Manrique Ronquillo

    Research Scientist
    Microviable Tx

    Pilar Manrique Ronquillo

    Research Scientist
    Microviable Tx
  • Author:

    Rosanne Hertzberger

    PI
    Vrije Universiteit Amsterdam

    Rosanne Hertzberger

    PI
    Vrije Universiteit Amsterdam
  • Author:

    Lothar Steidler

    CTO
    ActoBio Tx

    Lothar Steidler

    CTO
    ActoBio Tx
  • Author:

    Amine Zorgani

    Director, R&D
    S-Biomedic

    Amine Zorgani

    Director, R&D
    S-Biomedic
  • Author:

    Jonathan Swann

    Professor
    University of Southampton

    Jonathan Swann

    Professor
    University of Southampton
  • Author:

    Selin Bolca

    Head of Development
    MRM Health

    Selin Bolca

    Head of Development
    MRM Health
  • Author:

    Johan E.T. van Hylckama Vlieg

    Chief Scientific Officer
    Freya Biosciences

    Johan E.T. van Hylckama Vlieg

    Chief Scientific Officer
    Freya Biosciences